SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-020180
Filing Date
2021-10-18
Accepted
2021-10-18 16:14:10
Documents
2
Period of Report
2021-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163458803684092.html 3  
1 FORM 3 wf-form3_163458803684092.xml 3 1687
2 POA DE CRAEKER powerofattorney.htm EX-24 3733
  Complete submission text file 0001628280-21-020180.txt   6917
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address
de Craecker Francoise (Reporting) CIK: 0001887843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 211328416